Status:
COMPLETED
European iNvestigation of SUrveillance After Resection for Esophageal Cancer
Lead Sponsor:
St. James's Hospital, Ireland
Collaborating Sponsors:
St Mary's Hospital, Paddington, London
Karolinska Institutet
Conditions:
Esophageal Cancer
Metastatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The ENSURE study will comprise two phases. Phase 1: European multicenter survey of surveillance protocols after esophageal cancer surgery ENSURE questionnaire will be circulated to representatives f...
Detailed Description
Despite significant improvements in oncologic outcome for patients with esophageal cancer, with increased early detection and greater utilization of multimodal protocols,approximately 50% and 20% pati...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Age 18 years and above
- Underwent surgery with curative intent for cTxNxM0 esophageal or esophagogastric junction (Siewert type I, II and III) cancer
- Salvage surgery after failure of primary endoscopic or oncologic treatment will be included
- Exclusion criteria
- Endoscopic therapy or definitive oncological treatment as sole therapy for esophageal cancer
- Missing follow-up data
Exclusion
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2019
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT03461341
Start Date
June 1 2009
End Date
April 1 2019
Last Update
March 26 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, St. James's Hospital
Dublin, Ireland, D4
2
Karolinska Institutet
Stockholm, Sweden
3
Department of Surgery and Cancer, 10th Floor, QEQM building, St. Mary's Hospital
London, United Kingdom, W21NY